Financhill
Back

Inhibrx 10K Form

Buy
82

INBX
Inhibrx

Last Price:
32.53
Seasonality Move:
-22.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INBX News And Ratings

See the #1 stock for the next 7 days that we like better than INBX

INBX Financial Statistics

Sales & Book Value

Annual Sales: $7.13M
Cash Flow: $-30.82M
Price / Cash Flow: 0
Annual Sales: $-0.90
Price / Book: 0

Profitability

EPS (TTM): -3.22000
Net Income (TTM): $-125.5M
Gross Margin: --
Return on Equity: -923.32%
Return on Assets: -78.55%

Inhibrx Earnings Forecast

Key Inhibrx Financial Ratios

  • The Research & Development expenses have been 1,001.96% of Revenue.
  • The Interest Expense is -6.38% of Operating Income.
  • The Net Earning history of INBX is -1,146.84% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Inhibrx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: INBX
Website: inhibrx.com

Debt

Debt-to-Equity Ratio: -4.87
Current Ratio: 6.05
Quick Ratio: 5.76

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INBX Technical Analysis vs Fundamental Analysis

Buy
82
Inhibrx (INBX) is a Buy

Is Inhibrx a Buy or a Sell?

  • Inhibrx stock is rated a Buy
    The current Inhibrx [INBX] share price is $32.50. The Score for INBX is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.